Sopan Pharmaceuticals Closing IPO to General Public from Today
April 21, 2026 | Investopaper
After the first phase, Sopan Pharmaceuticals Limited is currently selling the shares to the general public in the second phase of an initial public offering (IPO). The IPO to general public is open from Baisakh 3, 2083 BS.
The company is selling 34,74,900 shares at Rs. 100 per share to the general public.
Interested investors can apply for a minimum of 10 shares and a maximum of 11,000 shares.
The public offering will close on Baisakh 8, 2083 BS.
The company has allotted 2,14,500 shares to the mutual fund schemes and has reserved 171,600 shares to the employees of the company.
In total (including the first and second phase), the company plans to issue 42.90 lakh shares to the public. This is 25 percent of the total issued capital of the company.
First Phase: IPO To Foreign Employed Nepalis
In the first phase of the IPO, the company had sold the shares to the Nepalis in foreign employment from Chaitra 9, 2082 BS..
The company had issued 4,29,000 shares (10 percent of general public’s quota) to the foreign employed Nepalis. The IPO to foreign employed Nepalis was closed on Chaitra 12, 2082 BS. Interested foreign employed Nepalis could apply for a minimum of 10 shares and a maximum of 11,000 shares.
Securities Board Of Nepal (SEBON) gave the permission to the company on Falgun 17, 2082 BS. Only after the approval from the regulatory body SEBON, the company can sell shares to the public.
The company has appointed NMB Capital Limited as the issue and sales manager for the IPO.
At present, the company has a paid-up capital of Rs. 128.70 crores. After the IPO (if fully subscribed), the capital will increase to Rs. 171.60 crores.
Sopan Pharmaceuticals Limited is a newly established pharmaceuticals company which formally inaugurated its first ever commercial batch production in the year 2078 BS.
Recommended:
